Four technologies to profile your AAVs

You need to profile your AAV vector to ensure you are developing an effective gene therapy delivery system. In this mini-guide, learn about 4 technologies that give you a full stability profile of your gene therapy vector. From serotype assessment, to monitoring aggregate formation, to checking vector purity, to evaluating capsid assembly and genetic fill — these  4 technologies will help you identify the best formulation and multi-parameter quality control of AAVs, so you build more effective gene therapy vectors.

Previous
The biologics researcher's guide to DLS
The biologics researcher's guide to DLS

Up next
8 Gene Therapy conferences you should attend in 2022
8 Gene Therapy conferences you should attend in 2022

With the first AAV-based gene therapies approved, and new gene editing strategies emerging, it’s important ...

Ready to tackle your challenging stability characterizations?

Discover tools